Summary of the project
This project is a chance to get together a consortium of 10 academic and industrial partners who have joined forces to develop disruptive and transformative approaches to the diagnosis, prognosis and treatment of developmental and epileptic encephalopathies linked to genes coding for potassium channels.
Workpackages
The work packages of the INNOV4-ePiK project outline the various stages and areas of activity required to achieve its goals. Explore the key actions undertaken in each area.
Impact
Beyond the RHU: Paving the way towards a new paradigm for therapy development in other K-DEEs, channels-DEEs, monogenic rare epilepsies & other non-DEE-channelopathies.
- Early diagnosis and accurate prognosis
- New treatment options
- Precision medicine trials in K-DEEs
- Better healthcare management
- Better knowledge of epidemiology
- Improve the understanding of evolution of rare epilepsies
- Medicoeconomics study
- Scientific approach transposable to other rare and ultra rare diseases
Pr. Rima Nabbout
Rima Nabbout has been a professor of Paediatric Neurology since 2014, and the director of the National Centre for Rare Epilepsies since 2006 at Necker-Enfants Malades Hospital. She received a MD in 1990, a Ph.D. in Neurosciences in 2003, and a « Habilitation à Diriger des Recherches » (Accreditation to supervise research) in 2010. More recently, she holds a research and academic position at Imagine Institute in the team “Translational Research for Neurological Diseases” where she leads the epilepsy research program.
Consortium
The INNOV4-ePiK project consortium brings together key partners and collaborators from various sectors to ensure the success of the initiative. Here, you can learn more about the main contributors driving the project forward.
Innov4-ePiK origin
GEEN-DS Chair
This project aims to understand the underlying molecular mechanisms by combining cutting-edge patient data, public health data, and environmental data to identify and test innovative therapies.
